American Assets Investment Management’s Gilead Sciences GILD Stock Holding History

American Assets Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.21M	Hold	23,000	–	–	0.22%	99
2025 Q4	$2.82M	Hold	23,000	–	–	0.19%	105
2025 Q3	$2.55M	Hold	23,000	–	–	0.19%	106
2025 Q2	$2.55M	Hold	23,000	–	–	0.21%	104
2025 Q1	$2.58M	Hold	23,000	–	–	0.23%	103
2024 Q4	$2.12M	Hold	23,000	–	–	0.17%	113
2024 Q3	$1.93M	Hold	23,000	–	–	0.17%	121
2024 Q2	$1.58M	Hold	23,000	–	–	0.15%	125
2024 Q1	$1.68M	Hold	23,000	–	–	0.16%	125
2023 Q4	$1.86M	Hold	23,000	–	–	0.19%	117
2023 Q3	$1.72M	Hold	23,000	–	–	0.19%	120
2023 Q2	$1.77M	Hold	23,000	–	–	0.2%	122
2023 Q1	$1.91M	Hold	23,000	–	–	0.22%	116
2022 Q4	$1.97M	Hold	23,000	–	–	0.23%	104
2022 Q3	$1.42M	Hold	23,000	–	–	0.18%	116
2022 Q2	$1.42M	Hold	23,000	–	–	0.18%	118
2022 Q1	$1.37M	Hold	23,000	–	–	0.14%	133
2021 Q4	$1.67M	Hold	23,000	–	–	0.18%	122
2021 Q3	$1.61M	Hold	23,000	–	–	0.2%	118
2021 Q2	$1.58M	Hold	23,000	–	–	0.21%	109
2021 Q1	$1.49M	Hold	23,000	–	–	0.21%	106
2020 Q4	$1.34M	Sell	23,000 -15,000	-39%	-$905K	0.22%	104
2020 Q3	$2.4M	Hold	38,000	–	–	0.49%	65
2020 Q2	$2.92M	Sell	38,000 -13,000	-25%	-$996K	0.66%	46
2020 Q1	$3.81M	Buy	51,000 +45,000	+750%	+$3.11M	0.82%	37
2019 Q4	$390K	Sell	6,000 -42,000	-88%	-$2.74M	0.06%	160
2019 Q3	$3.04M	Hold	48,000	–	–	0.49%	54
2019 Q2	$3.24M	Hold	48,000	–	–	0.52%	53
2019 Q1	$3.06M	Buy	48,000 +6,000	+14%	+$399K	0.5%	54
2018 Q4	$2.63M	Hold	42,000	–	–	0.47%	59
2018 Q3	$3.22M	Hold	42,000	–	–	0.53%	58
2018 Q2	$2.95M	Hold	42,000	–	–	0.52%	58
2018 Q1	$3.17M	Buy	42,000 +2,000	+5%	+$159K	0.6%	50
2017 Q4	$2.87M	Sell	40,000 -410	-1%	-$31.1K	0.55%	54
2017 Q3	$3.27M	Sell	40,410 -15,380	-28%	-$1.18M	0.65%	49
2017 Q2	$3.95M	Sell	55,790 -12,000	-18%	-$799K	0.82%	33
2017 Q1	$4.6M	Buy	67,790 +62,790	+1,256%	+$4.42M	0.94%	23
2016 Q4	$358K	Buy	+5,000	New	+$372K	0.08%	134

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Assets Investment Management's GILD Position: Q1 2026 in Review

American Assets Investment Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 23,000 shares worth $3.21M. The position accounts for 0.22% of the portfolio, ranked #99.

American Assets Investment Management first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. The position peaked at $4.6M in Q1 2017. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

American Assets Investment Management held 23,000 shares of Gilead Sciences worth $3.21M as of Q1 2026.
American Assets Investment Management left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.22% of American Assets Investment Management's portfolio in Q1 2026, its #99 holding.
American Assets Investment Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
American Assets Investment Management's Gilead Sciences position peaked at $4.6M in Q1 2017.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on American Assets Investment Management's 13F filing for Q1 2026, filed 11 May 2026.